Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Claudio Laudani on Comparison of Target and Non-target Vessel Revascularization for Recurrent ACS
Claudio Laudani/LinkedIn
Dec 24, 2025, 02:18

Claudio Laudani on Comparison of Target and Non-target Vessel Revascularization for Recurrent ACS

Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:

”Patients undergoing repeat revascularization for recurrent acute coronary syndrome represent a particularly high-risk population, yet limited data exist on whether outcomes differ between target-vessel and non-target-vessel revascularization.

In our latest study from the CAST Registry, published in Journal of Cardiovascular Medicine, we analyzed 299 patients undergoing repeat PCI for ACS, and compared the long-term outcomes of patients undergoing TVR vs. non-TVR.

Alos, we explored the predictors of long-term adverse events in this high-risk population.

In our study, we found that:

  • Patients undergoing repeat PCI for ACS represent a very high risk population, with most of the patients presenting with not at target LDL levels.
  • This high thrombotic risk is also reflected in the follow-up event rate, as MACE rates were as high as 37% at 3 years.
  • There were no significant differences between TVR and non-TVR, suggesting that recurrent ischemia is the reflection of a systematic high thrombotic burden phenotype rather than local procedure failure.
  • Variables of procedural complexity were the main predictors of long-term events, including cardiogenic shock at presentation, longer fluoroscopy time, and LAD involvement.

Overall, our data highlight that patients undergoing repeat PCI require a more aggressive treatment to prevent long-term adverse events.”

Read the full article here.

Article: Long-term outcomes of percutaneous coronary intervention for recurrent events in patients undergoing target-vessel vs. nontarget-vessel revascularization

Authors: Simone Finocchiaro, Maria Sara Mauro, Claudio Laudani, Davide Landolina, Placido Maria Mazzone, Antonino Imbesi, Marco Spagnolo, Antonio Greco, Francesco Nasisi, Davide Capodanno

Claudio Laudani on Comparison of Target and Non-target Vessel Revascularization for Recurrent ACS

Stay updated on all scientific advances with Hemostasis Today.

ACS Antonino Imbesi Antonio Greco Claudio Laudani Davide Capodanno Davide Landolina Francesco Nasisi Health Hematology Hemostasis Hemostasis Today Journal of Cardiovascular Medicine Marco Spagnolo Maria Sara Mauro Medicine non-TVR PCI Placido Maria Mazzone Simone Finocchiaro thrombosis TVR
NewsFeed